Faculty Opinions recommendation of Beta blockers and breast cancer mortality: a population- based study.

Author(s):  
Ellen Chang ◽  
Daphne Lichtensztajn
2015 ◽  
Vol 21 (5) ◽  
pp. 567-569 ◽  
Author(s):  
Isabelle Ribeiro Barbosa ◽  
María Milagros Bernal ◽  
Íris do Céu Clara Costa ◽  
Dyego Leandro Bezerra de Souza

2009 ◽  
Vol 23 (11) ◽  
pp. 4022-4028 ◽  
Author(s):  
Xinran Xu ◽  
Marilie D. Gammon ◽  
Steven H. Zeisel ◽  
Patrick T. Bradshaw ◽  
James G. Wetmur ◽  
...  

2020 ◽  
pp. 096914132095077
Author(s):  
Nathan Dunn ◽  
Philippa Youl ◽  
Julie Moore ◽  
Hazel Harden ◽  
Euan Walpole ◽  
...  

Objective In the context of a mature mammographic screening programme, the aim of this population-based study was to estimate rates of breast-cancer mortality among participants versus non-participants in Queensland, Australia. Methods The Queensland Electoral Roll was used to identify women aged 50–65  in the year 2000 (n = 269,198). Women with a prior history of invasive or in situ breast cancer were excluded (n = 6,848). The study population was then linked to mammography records from BreastScreen Queensland together with the Wesley Breast Screening Clinic (the largest provider of private screening in Queensland) to establish a screened cohort (n = 187,558) and an unscreened cohort (n = 74,792). Cohort members were matched and linked to cancer notifications and deaths through the state-based Queensland Oncology Repository. Differences in breast-cancer mortality between the two cohorts were measured using Cox proportional hazards regression. Results After 16 years of follow-up, women in the screened cohort showed a 39% reduction in breast-cancer mortality compared to the unscreened cohort (HR = 0.61, 95%CI = 0.55–0.68). Cumulative mortality over the same period was 0.47% and 0.77% in the screened and unscreened cohorts, respectively. Conclusions This study found a significant reduction in breast-cancer mortality for women who participated in mammographic screening compared to unscreened women. Our findings of a breast-cancer mortality benefit for women who have mammographic screening are in line with other observational studies.


Sign in / Sign up

Export Citation Format

Share Document